IBDEI1XS ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,30930,0)
;;=N06.5^^123^1597^37
;;^UTILITY(U,$J,358.3,30930,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30930,1,3,0)
;;=3^Isolated proteinuria w/ diffuse mesangiocapillary glomrlneph
;;^UTILITY(U,$J,358.3,30930,1,4,0)
;;=4^N06.5
;;^UTILITY(U,$J,358.3,30930,2)
;;=^5015554
;;^UTILITY(U,$J,358.3,30931,0)
;;=N06.6^^123^1597^32
;;^UTILITY(U,$J,358.3,30931,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30931,1,3,0)
;;=3^Isolated proteinuria w/ dense deposit disease
;;^UTILITY(U,$J,358.3,30931,1,4,0)
;;=4^N06.6
;;^UTILITY(U,$J,358.3,30931,2)
;;=^5015555
;;^UTILITY(U,$J,358.3,30932,0)
;;=N06.7^^123^1597^33
;;^UTILITY(U,$J,358.3,30932,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30932,1,3,0)
;;=3^Isolated proteinuria w/ diffuse crescentic glomerulonephritis
;;^UTILITY(U,$J,358.3,30932,1,4,0)
;;=4^N06.7
;;^UTILITY(U,$J,358.3,30932,2)
;;=^5015556
;;^UTILITY(U,$J,358.3,30933,0)
;;=N06.8^^123^1597^40
;;^UTILITY(U,$J,358.3,30933,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30933,1,3,0)
;;=3^Isolated proteinuria w/ other morphologic lesion
;;^UTILITY(U,$J,358.3,30933,1,4,0)
;;=4^N06.8
;;^UTILITY(U,$J,358.3,30933,2)
;;=^5015557
;;^UTILITY(U,$J,358.3,30934,0)
;;=N06.9^^123^1597^41
;;^UTILITY(U,$J,358.3,30934,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30934,1,3,0)
;;=3^Isolated proteinuria w/ unspecified morphologic lesion
;;^UTILITY(U,$J,358.3,30934,1,4,0)
;;=4^N06.9
;;^UTILITY(U,$J,358.3,30934,2)
;;=^5015558
;;^UTILITY(U,$J,358.3,30935,0)
;;=N07.0^^123^1597^29
;;^UTILITY(U,$J,358.3,30935,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30935,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ minor glomerular abnormality
;;^UTILITY(U,$J,358.3,30935,1,4,0)
;;=4^N07.0
;;^UTILITY(U,$J,358.3,30935,2)
;;=^5015559
;;^UTILITY(U,$J,358.3,30936,0)
;;=N07.1^^123^1597^28
;;^UTILITY(U,$J,358.3,30936,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30936,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ focal & seg glomerular lesions
;;^UTILITY(U,$J,358.3,30936,1,4,0)
;;=4^N07.1
;;^UTILITY(U,$J,358.3,30936,2)
;;=^5015560
;;^UTILITY(U,$J,358.3,30937,0)
;;=N07.2^^123^1597^24
;;^UTILITY(U,$J,358.3,30937,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30937,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ diffuse membranous glomrlneph
;;^UTILITY(U,$J,358.3,30937,1,4,0)
;;=4^N07.2
;;^UTILITY(U,$J,358.3,30937,2)
;;=^5015561
;;^UTILITY(U,$J,358.3,30938,0)
;;=N07.3^^123^1597^25
;;^UTILITY(U,$J,358.3,30938,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30938,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ diffuse mesangial prolif glomrlneph
;;^UTILITY(U,$J,358.3,30938,1,4,0)
;;=4^N07.3
;;^UTILITY(U,$J,358.3,30938,2)
;;=^5015562
;;^UTILITY(U,$J,358.3,30939,0)
;;=N07.4^^123^1597^23
;;^UTILITY(U,$J,358.3,30939,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30939,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ diffus endocaplry prolif glomrlneph
;;^UTILITY(U,$J,358.3,30939,1,4,0)
;;=4^N07.4
;;^UTILITY(U,$J,358.3,30939,2)
;;=^5015563
;;^UTILITY(U,$J,358.3,30940,0)
;;=N07.5^^123^1597^26
;;^UTILITY(U,$J,358.3,30940,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30940,1,3,0)
;;=3^Hereditary nephropathy, NEC w/ diffuse mesangiocap glomrlneph
;;^UTILITY(U,$J,358.3,30940,1,4,0)
;;=4^N07.5
;;^UTILITY(U,$J,358.3,30940,2)
;;=^5015564
;;^UTILITY(U,$J,358.3,30941,0)
;;=N07.6^^123^1597^22
;;^UTILITY(U,$J,358.3,30941,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1XS 3791 printed Apr 09, 2024@20:51:57 Page 2
IBDEI1XS ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,30930,0)
+2 ;;=N06.5^^123^1597^37
+3 ;;^UTILITY(U,$J,358.3,30930,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,30930,1,3,0)
+6 ;;=3^Isolated proteinuria w/ diffuse mesangiocapillary glomrlneph
+7 ;;^UTILITY(U,$J,358.3,30930,1,4,0)
+8 ;;=4^N06.5
+9 ;;^UTILITY(U,$J,358.3,30930,2)
+10 ;;=^5015554
+11 ;;^UTILITY(U,$J,358.3,30931,0)
+12 ;;=N06.6^^123^1597^32
+13 ;;^UTILITY(U,$J,358.3,30931,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,30931,1,3,0)
+16 ;;=3^Isolated proteinuria w/ dense deposit disease
+17 ;;^UTILITY(U,$J,358.3,30931,1,4,0)
+18 ;;=4^N06.6
+19 ;;^UTILITY(U,$J,358.3,30931,2)
+20 ;;=^5015555
+21 ;;^UTILITY(U,$J,358.3,30932,0)
+22 ;;=N06.7^^123^1597^33
+23 ;;^UTILITY(U,$J,358.3,30932,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,30932,1,3,0)
+26 ;;=3^Isolated proteinuria w/ diffuse crescentic glomerulonephritis
+27 ;;^UTILITY(U,$J,358.3,30932,1,4,0)
+28 ;;=4^N06.7
+29 ;;^UTILITY(U,$J,358.3,30932,2)
+30 ;;=^5015556
+31 ;;^UTILITY(U,$J,358.3,30933,0)
+32 ;;=N06.8^^123^1597^40
+33 ;;^UTILITY(U,$J,358.3,30933,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,30933,1,3,0)
+36 ;;=3^Isolated proteinuria w/ other morphologic lesion
+37 ;;^UTILITY(U,$J,358.3,30933,1,4,0)
+38 ;;=4^N06.8
+39 ;;^UTILITY(U,$J,358.3,30933,2)
+40 ;;=^5015557
+41 ;;^UTILITY(U,$J,358.3,30934,0)
+42 ;;=N06.9^^123^1597^41
+43 ;;^UTILITY(U,$J,358.3,30934,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,30934,1,3,0)
+46 ;;=3^Isolated proteinuria w/ unspecified morphologic lesion
+47 ;;^UTILITY(U,$J,358.3,30934,1,4,0)
+48 ;;=4^N06.9
+49 ;;^UTILITY(U,$J,358.3,30934,2)
+50 ;;=^5015558
+51 ;;^UTILITY(U,$J,358.3,30935,0)
+52 ;;=N07.0^^123^1597^29
+53 ;;^UTILITY(U,$J,358.3,30935,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,30935,1,3,0)
+56 ;;=3^Hereditary nephropathy, NEC w/ minor glomerular abnormality
+57 ;;^UTILITY(U,$J,358.3,30935,1,4,0)
+58 ;;=4^N07.0
+59 ;;^UTILITY(U,$J,358.3,30935,2)
+60 ;;=^5015559
+61 ;;^UTILITY(U,$J,358.3,30936,0)
+62 ;;=N07.1^^123^1597^28
+63 ;;^UTILITY(U,$J,358.3,30936,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,30936,1,3,0)
+66 ;;=3^Hereditary nephropathy, NEC w/ focal & seg glomerular lesions
+67 ;;^UTILITY(U,$J,358.3,30936,1,4,0)
+68 ;;=4^N07.1
+69 ;;^UTILITY(U,$J,358.3,30936,2)
+70 ;;=^5015560
+71 ;;^UTILITY(U,$J,358.3,30937,0)
+72 ;;=N07.2^^123^1597^24
+73 ;;^UTILITY(U,$J,358.3,30937,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,30937,1,3,0)
+76 ;;=3^Hereditary nephropathy, NEC w/ diffuse membranous glomrlneph
+77 ;;^UTILITY(U,$J,358.3,30937,1,4,0)
+78 ;;=4^N07.2
+79 ;;^UTILITY(U,$J,358.3,30937,2)
+80 ;;=^5015561
+81 ;;^UTILITY(U,$J,358.3,30938,0)
+82 ;;=N07.3^^123^1597^25
+83 ;;^UTILITY(U,$J,358.3,30938,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,30938,1,3,0)
+86 ;;=3^Hereditary nephropathy, NEC w/ diffuse mesangial prolif glomrlneph
+87 ;;^UTILITY(U,$J,358.3,30938,1,4,0)
+88 ;;=4^N07.3
+89 ;;^UTILITY(U,$J,358.3,30938,2)
+90 ;;=^5015562
+91 ;;^UTILITY(U,$J,358.3,30939,0)
+92 ;;=N07.4^^123^1597^23
+93 ;;^UTILITY(U,$J,358.3,30939,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,30939,1,3,0)
+96 ;;=3^Hereditary nephropathy, NEC w/ diffus endocaplry prolif glomrlneph
+97 ;;^UTILITY(U,$J,358.3,30939,1,4,0)
+98 ;;=4^N07.4
+99 ;;^UTILITY(U,$J,358.3,30939,2)
+100 ;;=^5015563
+101 ;;^UTILITY(U,$J,358.3,30940,0)
+102 ;;=N07.5^^123^1597^26
+103 ;;^UTILITY(U,$J,358.3,30940,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,30940,1,3,0)
+106 ;;=3^Hereditary nephropathy, NEC w/ diffuse mesangiocap glomrlneph
+107 ;;^UTILITY(U,$J,358.3,30940,1,4,0)
+108 ;;=4^N07.5
+109 ;;^UTILITY(U,$J,358.3,30940,2)
+110 ;;=^5015564
+111 ;;^UTILITY(U,$J,358.3,30941,0)
+112 ;;=N07.6^^123^1597^22
+113 ;;^UTILITY(U,$J,358.3,30941,1,0)
+114 ;;=^358.31IA^4^2
